Citable filing context
EMR's research view summarizes recent SEC filing context, starting with earnings from Aug 4, 2026.
| Filed | Item | Context |
|---|---|---|
| Aug 4, 2026 | earnings | Emerson reported Q3 2026 net sales of $4.87B, up 7%, and raised its full-year outlook. |
| Feb 13, 2026 | debt_offering | Emerson Electric Co. entered into a $2 billion 364-day unsecured credit facility on February 10, 2026. |
| Feb 6, 2026 | other | Emerson Electric Co. held its 2026 Annual Meeting of Shareholders on February 3, 2026. |
| Aug 4, 2026 | Guidance: adjusted_earnings_per_share | not reported to 6.55 |
| Aug 4, 2026 | Guidance: earnings_per_share | not reported to 4.89 |
| Aug 4, 2026 | Guidance: free_cash_flow | not reported to 3.60 |
| Aug 4, 2026 | mda_quarterly | Emerson reported strong third-quarter fiscal 2026 results, with net sales of $4.9 billion, a 7% increase year-over-year. Underlying sales grew 6%, driven by 3% higher volume and 3% higher pricing. Growth was particularly robust in the Americas and Asia, Middle East & Africa, both up 8%, while Europe saw a 1% decline. By segment, Software & Systems led with 11% sales growth, fueled by strength in power, semiconductor, and aerospace & defense markets. Intelligent Devices grew 6%, supported by power and LNG demand, while Safety & Productivity rose 3%. Profitability improved, with diluted EPS from continuing operations rising 24% to $1.28. Adjusted diluted EPS reached $1.71, a 13% increase. Results were bolstered by $82 million in IEEPA tariff refunds, which positively impacted gross margins. Operating cash flow and free cash flow remain strong at $2.9 billion and $2.6 billion for the nine-month period, respectively. Management maintains a conservative capital structure, supported by a $2 billion revolving credit facility. For fiscal 2026, the company projects consolidated net sales growth of approximately 5% and adjusted diluted EPS of $6.55, with plans to return $2.2 billion to shareholders through dividends and share repurchases. |
| May 5, 2026 | mda_quarterly | Net sales for the second quarter of fiscal 2026 rose 3% to $4.6 billion, with adjusted diluted earnings per share increasing 4% to $1.54. Underlying sales growth of 0.5% was constrained by a 2% negative impact from software renewal timing and a 1% drag from the Middle East conflict. Gross margin declined 40 basis points to 53.1%, pressured by tariffs and software renewal timing, though the company may be eligible for IEEPA tariff refunds following a U.S. Supreme Court ruling. Within Software & Systems, Test & Measurement sales grew 16% driven by aerospace, defense, and semiconductor demand, while Control Systems & Software faced renewal timing headwinds despite strength in power and life sciences. Intelligent Devices sales grew 2%, with Americas-based power and LNG growth offsetting a 13% decline in China. Safety & Productivity sales rose 5% through pricing actions. The One Big Beautiful Bill Act increased the current effective tax rate but is expected to provide a benefit in fiscal 2027. For the full year 2026, the company forecasts net sales growth of approximately 4.5% and adjusted earnings per share between $6.45 and $6.55, with projected free cash flow of $3.5 to $3.6 billion. |
Source: SEC EDGAR filing text and events; period Aug 4, 2026; filed Aug 4, 2026.
EMR company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.